Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy (Q40387387)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy |
scientific article |
Statements
1 reference
Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy (English)
1 reference
Thierry Facon
1 reference
Jean-Yves Mary
1 reference
Brigitte Pégourie
1 reference
Michel Attal
1 reference
Marc Renaud
1 reference
Alain Sadoun
1 reference
Laurent Voillat
1 reference
Véronique Dorvaux
1 reference
Cyrille Hulin
1 reference
Gérard Lepeu
1 reference
Jean-Luc Harousseau
1 reference
Jean-Paul Eschard
1 reference
Augustin Ferrant
1 reference
Michel Blanc
1 reference
Frédéric Maloisel
1 reference
Hubert Orfeuvre
1 reference
Jean-François Rossi
1 reference
Isabelle Azaïs
1 reference
Mathieu Monconduit
1 reference
Philippe Collet
1 reference
Bruno Anglaret
1 reference
Ibrahim Yakoub-Agha
1 reference
Marc Wetterwald
1 reference
Houchingue Eghbali
1 reference
Marie-Christine Vekemans
1 reference
Hervé Maisonneuve
1 reference
Jacques Troncy
1 reference
Bernard Grosbois
1 reference
Chantal Doyen
1 reference
Antoine Thyss
1 reference
Jérome Jaubert
1 reference
Philippe Casassus
1 reference
Béatrice Thielemans
1 reference
Régis Bataille
1 reference
Intergroupe Francophone du Myélome (IFM) group
1 reference
20 September 2005
1 reference
Identifiers
1 reference